)

10X Genomics (TXG) investor relations material
10X Genomics Morgan Stanley 23rd Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Key achievements and operational highlights
Completed commercial restructuring and made significant progress in product development, including the upcoming launch of Chromium Single Cell Gene Expression Flex V2.
Maintained strong cost management and further strengthened the balance sheet, positioning well for future growth.
Biopharma segment reorganized for better focus and visibility, with continued challenges in biotech funding but stable momentum in large pharma.
Majority of customers have transitioned to GenX consumables, with NextGen being phased out to accelerate final conversions.
Strategic acquisition of Scale Biosciences to enhance barcoding and scaling capabilities in single cell analysis.
Market environment and customer sentiment
Academic end markets remain cautious due to ongoing funding uncertainties, especially in the U.S., with no significant change in sentiment recently.
Global environment for capital equipment purchases is subdued, with increased scrutiny and pressure on instrument investments.
Biopharma customers, especially biotech, continue to face funding challenges, while large pharma remains cautious amid policy uncertainties.
Preference for consumables over capital equipment persists, with strong interest in both single cell and spatial applications.
Product innovation and competitive positioning
Chromium Flex V2 is set to launch later this year, offering enhanced sensitivity, robustness, and flexibility for large-scale and translational applications.
Flex V2 expected to enable new workflows and support the development of large-scale AI models in biology.
Single cell market shows strong elasticity, with lower price points driving increased reaction volumes and new applications.
Competitive landscape remains favorable, with superior data quality, sensitivity, and customer support cited as key differentiators.
Recent product introductions and the Scale acquisition address cost and scalability, further strengthening market position.
Next 10X Genomics earnings date

Next 10X Genomics earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage